Columbia Herbert Irving Cancer Center – Myelodysplastic Syndrome Program is a specialized cancer treatment center located in New York, New York. Focused on addressing myelodysplastic syndrome (MDS), a rare and complex blood disorder, the center provides comprehensive care tailored to the unique needs of patients facing this challenging diagnosis. Situated at 161 Fort Washington Avenue, the facility offers access to a multidisciplinary team of oncologists and hematologists dedicated to advancing treatment options and patient outcomes.
The program emphasizes personalized approaches to MDS management, integrating the latest research and clinical protocols to develop individualized care plans. Patients benefit from thorough diagnostic evaluations, including bone marrow biopsies and genetic testing, which guide targeted therapies designed to improve quality of life and disease prognosis. The center also coordinates supportive care services to address symptoms and treatment side effects, ensuring a holistic approach to patient well-being.
As part of the larger Herbert Irving Comprehensive Cancer Center, this program leverages extensive resources and expertise in cancer research and clinical practice. Collaboration among specialists facilitates innovative treatment strategies and participation in clinical trials, offering patients access to emerging therapies not widely available elsewhere. The facility’s location in New York City allows for convenient access to advanced medical technology and a broad network of healthcare professionals.
Columbia Herbert Irving Cancer Center – Myelodysplastic Syndrome Program maintains a focus on providing thorough, patient-centered cancer care. The team’s commitment to understanding the complexities of MDS and applying evidence-based treatments supports patients throughout their care journey. Individuals seeking expert consultation or treatment for myelodysplastic syndrome in New York can contact the center directly at 212-305-5098 for further information and appointment scheduling.
